フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
RESEARCH TRIANGLE PARK, N.C., Aug. 7 /PRNewswire/ -- Because wet weather from an active hurricane season brings with it increased insect...
NEW YORK, April 28 /PRNewswire/ -- MZ Consult NY LLC (http://www.mz-ir.com/), a leading investor relations and financial communication...
Editors are advised that a high-resolution photo is available to accompany the news release, NYTU092, FDA Approves Nexavar(R) for Treatment of...
Bayer Environmental Science Voluntarily Recalling Allectus(TM) Granular Products RESEARCH TRIANGLE PARK, N.C., July 26 /PRNewswire/ -- Bayer...
- New One-A-Day Cholesterol Plus with Policosanol is First Leading Multivitamin to Maintain Healthy Cholesterol and Blood Pressure...
/K I L L K I L L K I L L -- Quality Food Grade Carriers/ Journalists and other readers should disregard the news release "Quality Distribution...
New Adult Hemophilia Quality of Life Tool Now Available for Hemophilia Community Multinational Validation Study of Haemo-Qol-A Presented at WFH...
Fire Ants a Growing Liability Concern for Elder Care Facilities; Experts Suggest Preventative Measures MONTVALE, N.J., Aug. 12 /PRNewswire/...
Bayer Biological Products Launches Initiative to Aid Kogenate(R) FS Patients Multi-faceted patient assistance initiative developed in response to...
Largest Randomized, Prospective Idiopathic [Immune] Thrombocytopenic Purpura (ITP) Study to Date Shows Gamunex(R) Safe and Efficacious for...
Study Shows Patients Treated With Avelox(R) (Moxifloxacin HCI) Recovered Faster from Flare-Ups of Chronic Bronchitis Than Patients Treated With...
FDA Approves Avelox(R) (moxifloxacin HCI) for Community Acquired Pneumonia Due to Multi-Drug Resistant Streptococcus pneumoniae Approval Marks...
/C O R R E C T I O N -- Bayer Pharmaceuticals Corporation/ In the news release, FDA Approves Avelox(R) (moxifloxacin HCI) for Community Acquired...
Clinical Trial Investigates Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) with Gamunex(R), Immune Globulin Intravenous...
Support
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
サインアップして広告なしのエクスペリエンスを体験してください
今すぐ試してください
広告を残す